Valneva’s Lyme Disease Jab Program Gets Pfizer Cash Boost

Through Equity Subscription Agreement

Pfizer's Support Gives Valneva A Cash Boost • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip